Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices
NHS hospitals in England used £793,917,034 of indicative cost of Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 3.1% of all hospital medicines spend. That is up 71.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £25,698,459 |
| Cambridge Univ Hosp Nhs Foundation Trust | £24,110,296 |
| Leeds Teaching Hpls Nhs Trust | £23,648,217 |
| Western Sussex Hospitals Nhs Found Trust | £21,655,084 |
| Barts Health Nhs Trust | £21,070,178 |
| Manchester University Nhs Ft | £18,941,330 |
| Guy's & St Thomas' Nhs Foundation Trust | £17,458,955 |
| Nottingham University Hospitals Trust | £17,172,462 |
| University Hpls Of Leicester Nhs Trust | £16,876,487 |
| Southend Univ Hosp Nhs Foundation Trust | £15,692,980 |
The primary-care picture
Adalimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Adalimumab medicine page.